Literature DB >> 14351793

Oral preparations of Reuwolfia serpentina in treatment of essential hypertension.

S LOCKET.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; INFANT WELFARE; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 14351793      PMCID： PMC2061915          DOI： 10.1136/bmj.1.4917.809

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Arterial hypertension treated with Rauwolfia serpentina and veratrum viride.

Authors:  C JOINER; R KAUNTZE
Journal:  Lancet       Date:  1954-05-29       Impact factor: 79.321

2.  [Therapy of hypertension with Indian Rauwolfia serpentina].

Authors:  F VIDA
Journal:  Medizinische       Date:  1952-09-13

3.  [New results in medicamentous treatment of arterial hypertonia].

Authors:  O H ARNOLD; K D BOCK
Journal:  Dtsch Med Wochenschr       Date:  1953-06-12       Impact factor: 0.628

4.  The medical management of arterial hypertension.

Authors:  E MEILMAN
Journal:  N Engl J Med       Date:  1953-05-28       Impact factor: 91.245

5.  The medical management of arterial hypertension.

Authors:  E MEILMAN
Journal:  N Engl J Med       Date:  1953-05-21       Impact factor: 91.245

6.  M. & B. 1863, a homologue of hexamethonium, in treatment of hypertension.

Authors:  S LOCKET; P G SWANN; W S GRIEVE; H P PLAYER
Journal:  Br Med J       Date:  1952-02-02

7.  Methonium compounds in the treatment of hypertension.

Authors:  S LOCKET; P G SWANN; W S M GRIEVE
Journal:  Br Med J       Date:  1951-04-14
  7 in total
  6 in total

1.  Methoserpidine, a non-depressant isomer of reserpine.

Authors:  M C HOLT
Journal:  Br Med J       Date:  1961-08-12

2.  Cardiac failure with reserpine.

Authors:  E MARLEY; C M PARE
Journal:  Br Med J       Date:  1956-02-04

3.  Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

Authors:  G LEMIEUX; A DAVIGNON; J GENEST
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

4.  Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

5.  The features of reserpine-induced gastric mucosal lesions.

Authors:  Xiu-juan Ma; Guo-cai Lu; Shu-wei Song; Wei Liu; Zhi-peng Wen; Xiang Zheng; Qian-zhou Lü; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

6.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.